Krebs Biochemicals And Industries Limited - Company Profile

It is a life sciences public limited company based in Anakapalli, Telangana, India, established in 1991.

1991 Anakapalli, Telangana, India Active

Last Updated: December 23, 2025

About Krebs Biochemicals And Industries Limited

Krebs Biochemicals And Industries Limited, a active public limited company, was established on 02 December 1991 in Anakapalli, Telangana, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: L24110AP1991PLC103912. Registered under ROC Roc Vijayawada. it is listed on BSE: 524518 and NSE: KREBSBIO. It has an authorized capital of ₹153.00 Cr and a paid-up capital of ₹151.56 Cr.

Formerly known as Krebs Biochemicals Limited. It upholds a compliant status. Employing 335 professional, Its leadership includes Sumanth Karlapudi (Director), Manish Padam Jain (Ceo), Ravi Ravindranath Tagore (Director). Past directors included Raj Kamal Prasad Verma, Sangeeta Sharma, Venkata Lakshmi Prasad Gundapaneni. It holds ₹14.35 Cr open charges and ₹285.88 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2024. It is based at Kothapalli Village Kasimkota Mandal,, Anakapalli, Telangana, 531031.

Company Details

CIN/LLPIN
L24110AP1991PLC103912
Registration Number
103912
Incorporation Date
02 December 1991
Authorized Capital
₹153.00 Cr
Paid-Up Capital
₹151.56 Cr
ROC Code
Roc Vijayawada
Listing Status
Listed (BSE: 524518, NSE: KREBSBIO)
Company Status
Active

Key Metrics

Authorised Capital ₹ 153.00 Cr as on 23-12-2025
Paid Up Capital ₹ 151.56 Cr as on 23-12-2025
Company Age 34 Year, 2 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 14.35 Cr as on 23-12-2025
Satisfied Charges ₹ 285.88 Cr as on 23-12-2025
Revenue Growth **** -13.32% (FY 2023)
Profit Growth **** 44.55% (FY 2023)
Ebitda **** 53.58% (FY 2023)
Net Worth -32.45% (FY 2023)
Total Assets -7.81% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Krebs Biochemicals And Industries Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Krebs Biochemicals And Industries Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sumanth Karlapudi	Director	04 Feb 2025	Current
Manish Padam Jain	Ceo	07 Aug 2025	Current
Ravi Ravindranath Tagore	Director	12 Oct 1992	Current
Pabitrakumar Kalipada Bhattacharyya	Director	10 Aug 2023	Current
Avinash Ravi	Director	13 Aug 2015	Current
Malati Tangirala	Director	13 Feb 2015	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2016	Past
Pramod Abcsdd	Nominee Director	08 Apr 2011	Past
Pramod Abcsdd	Director	01 Jan 2025	Past
Pramod Abcsdd	Director	10 Nov 2021	Past
Pramod Abcsdd	Additional Director	27 Sep 2007	Past
Pramod Abcsdd	Additional Director	27 Mar 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Krebs Biochemicals And Industries.

Krebs Biochemicals And Industries Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.32% decrease. The company also saw a substantial improvement in profitability, with a 44.55% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.45%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-13.32%

*******

Revenue from Operations

*******

-12.68%

*******

Total Assets

*******

-7.81%

*******

Profit or Loss

*******

44.55%

*******

Net Worth

*******

-32.45%

*******

EBITDA

*******

53.58%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Krebs Biochemicals And Industries?

In 2023, Krebs Biochemicals And Industries had a promoter holding of 72.74% and a public holding of 27.25%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹143,500,000.00

Satisfied Charges

₹2,858,780,313.00

Charges Breakdown by Lending Institutions

Others : 10.00 Cr
Industrial Development Bank Of India : 3.00 Cr
State Bank Of India : 1.35 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Aug 2021	Others	₹10.00 Cr	Open
16 Apr 1994	State Bank Of India	₹1.35 Cr	Open
19 Jan 1986	Industrial Development Bank Of India	₹3.00 Cr	Open
25 Aug 2020	Others	₹10.00 Cr	Satisfied
08 Sep 2011	Pinky Ventures Private Limited	₹2.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Krebs Biochemicals And Industries?

Krebs Biochemicals And Industries has a workforce of 335 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Krebs Biochemicals And Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krebs Biochemicals And Industries's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Krebs Biochemicals And Industries

Recent Activity within the Organization

Annual General Meeting

Krebs Biochemicals And Industries Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
26 Sep 2025
Director Appointment

Progress on Manish Kumar Jain was appointed as a Ceo was appointed as a Ceo on 14 Aug 2025 & has been associated with this company since 5 months 20 days . was documented.
14 Aug 2025
Director Appointment

Progress on Manish Padam Jain was appointed as a CEO was appointed as a CEO on 07 Aug 2025 & has been associated with this company since 5 months 27 days . was documented.
07 Aug 2025
Director Appointment

Progress on Sumanth Karlapudi was appointed as a Director was appointed as a Director on 04 Feb 2025 & has been associated with this company since 11 months 28 days . was documented.
04 Feb 2025
Director Appointment

Popatlal Mukanchand Kathariya was appointed as a Director was appointed as a Director on 04 Feb 2025 & has been associated with this company since 11 months 28 days . was recorded as a recent event.
04 Feb 2025
Director Appointment

Dipti Chinubhai Shah was appointed as a Director was appointed as a Director on 04 Feb 2025 & has been associated with this company since 11 months 28 days . was recorded as a recent event.
04 Feb 2025

Explore recent activity and updates - View Recent Activity